Y. Shishido et al., INVOLVEMENT OF PROTEASE INHIBITORS IN STAPHYLOKINASE-INDUCED FIBRIN-SPECIFIC FIBRINOLYSIS, Biological & pharmaceutical bulletin, 17(12), 1994, pp. 1595-1598
We compared the fibrinolytic properties of recombinant staphylokinase
(SAK), a fibrin-specific plasminogen activator, with those of streptok
inase and tissue-type plasminogen activator (t-PA) by means of the ami
dolytic method. We also investigated the involvement of alpha(2)-macro
globulin, C-1-inactivator and alpha(1)-antitrypsin in SAK-induced fibr
in-specific fibrinolysis. Both SAK and t-PA activated plasminogen effi
ciently in the presence of fibrin in human plasma. Although t-PA activ
ated plasminogen dependently on fibrin in the reconstituted plasma sys
tem, SAK activated plasminogen independently of fibrin without alpha(2
)-plasmin inhibitor (alpha(2)-antiplasmin, alpha(2)-PI). These finding
s suggest that fibrin and alpha(2)-PI play important roles in plasmino
gen activation by SAK but not by t-PA. Furthermore, protease inhibitor
s such as alpha(2)-PI, alpha(2)-macroglobulin, C-1-inactivator and alp
ha(1)-antitrypsin inhibited plasminogen activation by SAK and the inhi
bitory actions of these protease inhibitors disappeared in the presenc
e of fibrin. This shows that alpha(2)-macroglobulin, C-1-inactivator a
nd alpha(1)-antitrypsin, other than alpha(2)-PI, contribute to the fib
rin-specificity of SAK.